Grndad and Disease Modifying Therapy (DMT): Shifts in Dmt Are Seen at the Adolescent/Young Adult Transition in Sickle Cell Disease in a Multi-Site Prospective Registry
Document Type
Conference Proceeding
Publication Date
11-2-2023
Publication Title
Blood
Abstract
65th ASH Annual Meeting, December 9 - 12, 2023, San Diego, CA
First Page
798
Volume
142
Issue
Supplement 1
Recommended Citation
Lanzkron, Sophie; Manwani, Deepa; Kanter, Julie; Sinha, Arpan A.; Miller, Robin E.; Cronin, Robert; Jacob, Seethal A.; Harper, James; Anderson, Alan Randall; Treadwell, Marsha; Owusu-Ansah, Amma T.; Fuh, Beng R.; Mandernach, Molly; Gollamudi, Jahnavi; Saccente, Suzanne L.; Fritch Lilla, Stephanie A.; McNaull, Melissa; LeBlanc, Dana Marie; Saving, Kay Linn; Guarino, Stephanie H.; Betensky, Marisol; Cohen, Alice J.; Raj, Ashok B.; Sayani, Farzana A.; Shah, Sanjay J.; Narang, Shalu; Sathi, Bindu Kanathezhath; Strouse, John J.; Wong, Trisha E.; and al, et, "Grndad and Disease Modifying Therapy (DMT): Shifts in Dmt Are Seen at the Adolescent/Young Adult Transition in Sickle Cell Disease in a Multi-Site Prospective Registry" (2023). School of Medicine Faculty Publications. 3770.
https://digitalscholar.lsuhsc.edu/som_facpubs/3770
10.1182/blood-2023-174930
Comments
ORAL ABSTRACTS 114.SICKLE CELL DISEASE, SICKLE CELL TRAIT AND OTHER HEMOGLOBINOPATHIES, EXCLUDING THALASSEMIAS: CLINICAL AND EPIDEMIOLOGICAL